Author
Listed:
- Dimitri Belenki
(Campus Virchow Klinikum
Max Delbrück Center for Molecular Medicine in the Helmholtz Association)
- Paulina Richter-Pechanska
(Campus Virchow Klinikum)
- Zhiting Shao
(Campus Virchow Klinikum)
- Animesh Bhattacharya
(Campus Virchow Klinikum)
- Andrea Lau
(Campus Virchow Klinikum)
- José Américo Nabuco Leva Ferreira de Freitas
(Faculté de Médecine de Créteil)
- Gregor Kandler
(Campus Virchow Klinikum)
- Timon P. Hick
(Campus Virchow Klinikum
Humboldt-Universität zu Berlin)
- Xiurong Cai
(Campus Virchow Klinikum)
- Eva Scharnagl
(Medical Faculty)
- Aitomi Bittner
(Campus Virchow Klinikum)
- Martin Schönlein
(Campus Virchow Klinikum
University Medical Center Hamburg-Eppendorf
Vienna BioCenter (VBC))
- Julia Kase
(Campus Virchow Klinikum)
- Katharina Pardon
(Campus Virchow Klinikum)
- Bernadette Brzezicha
(Experimental Pharmacology & Oncology Berlin-Buch GmbH)
- Nina Thiessen
(Berlin Institute of Health)
- Oliver Bischof
(Faculté de Médecine de Créteil)
- Jan R. Dörr
(Campus Virchow Klinikum
Charité-Universitätsmedizin Berlin
Experimental and Clinical Research Center (ECRC) of the Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin)
- Maurice Reimann
(Campus Virchow Klinikum)
- Maja Milanovic
(Campus Virchow Klinikum
Campus Benjamin Franklin
partner site Berlin)
- Jing Du
(Medical Research Center and Department of Oncology Binzhou Medical University Hospital)
- Yong Yu
(Medical Faculty)
- Björn Chapuy
(Campus Benjamin Franklin)
- Soyoung Lee
(Campus Virchow Klinikum
Medical Faculty)
- Ulf Leser
(Humboldt-Universität zu Berlin)
- Claus Scheidereit
(Max Delbrück Center for Molecular Medicine in the Helmholtz Association)
- Jana Wolf
(Max Delbrück Center for Molecular Medicine in the Helmholtz Association
Free University Berlin)
- Dorothy N. Y. Fan
(Campus Virchow Klinikum
Max Delbrück Center for Molecular Medicine in the Helmholtz Association
partner site Berlin)
- Clemens A. Schmitt
(Campus Virchow Klinikum
Max Delbrück Center for Molecular Medicine in the Helmholtz Association
Medical Faculty
partner site Berlin)
Abstract
Cellular senescence is a stress-inducible state switch relevant in aging, tumorigenesis and cancer therapy. Beyond a lasting arrest, senescent cells are characterized by profound chromatin remodeling and transcriptional reprogramming. We show here myeloid-skewed aberrant lineage plasticity and its immunological ramifications in therapy-induced senescence (TIS) of primary human and murine B-cell lymphoma. We find myeloid transcription factor (TF) networks, specifically AP-1-, C/EBPβ- and PU.1-governed transcriptional programs, enriched in TIS but not in equally chemotherapy-exposed senescence-incapable cancer cells. Dependent on these master TF, TIS lymphoma cells adopt a lineage-promiscuous state with properties of monocytic-dendritic cell (DC) differentiation. TIS lymphoma cells are preferentially lysed by T-cells in vitro, and mice harboring DC-skewed Eμ-myc lymphoma experience significantly longer tumor-free survival. Consistently, superior long-term outcome is also achieved in diffuse large B-cell lymphoma patients with high expression of a TIS-related DC signature. In essence, these data demonstrate a therapeutically exploitable, prognostically favorable immunogenic role of senescence-dependent aberrant myeloid plasticity in B-cell lymphoma.
Suggested Citation
Dimitri Belenki & Paulina Richter-Pechanska & Zhiting Shao & Animesh Bhattacharya & Andrea Lau & José Américo Nabuco Leva Ferreira de Freitas & Gregor Kandler & Timon P. Hick & Xiurong Cai & Eva Schar, 2025.
"Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control,"
Nature Communications, Nature, vol. 16(1), pages 1-20, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-57429-x
DOI: 10.1038/s41467-025-57429-x
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-57429-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.